Tech Company Financing Transactions

Delfi Diagnostics Funding Round

Delfi Diagnostics secured a $225 million Series B funding round on 7/18/2022. Backers included DFJ Growth, AV8 Ventures and Brown Advisory.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
This funding will support the continued development and commercialization of high-quality and accessible blood tests for single cancer early detection, multi-cancer early detection, and treatment monitoring.

Company Information

Company Status
Private & Independent
Healthcare IT
Mailing Address
301 W. 29th St.
Baltimore, MD 21211
Email Address
Founded in 2019, Delfi Diagnostics is committed to developing high-performing, affordable blood tests for early detection of cancer across multiple tumor types. Leveraging recent advances in cancer biology and machine learning, DELFI's technology can achieve high performance from low-cost, widely available sequencing technology.
Delfi Diagnostics LinkedIn Company Profile
Social Media
Delfi Diagnostics Company Twitter Account
Company News
Delfi Diagnostics News
Delfi Diagnostics on Facebook
Delfi Diagnostics on YouTube

Management Team

Email & Social
Chief Executive Officer
Victor Velculescu
  Victor Velculescu LinkedIn Profile  Victor Velculescu Twitter Account  Victor Velculescu News  Victor Velculescu on Facebook
Chief Financial Officer
William Stevens
  William Stevens LinkedIn Profile  William Stevens Twitter Account  William Stevens News  William Stevens on Facebook
Chief Operating Officer
Jenn Buechel
  Jenn Buechel LinkedIn Profile  Jenn Buechel Twitter Account  Jenn Buechel News  Jenn Buechel on Facebook
Chief Scientific Officer
Nic Dracopoli
  Nic Dracopoli LinkedIn Profile  Nic Dracopoli Twitter Account  Nic Dracopoli News  Nic Dracopoli on Facebook
VP - Regulatory Affairs
Mya Thomae
  Mya Thomae LinkedIn Profile  Mya Thomae Twitter Account  Mya Thomae News  Mya Thomae on Facebook



Browse more venture capital transactions:

Prev: 7/18/2022: Syrius Robotics venture capital transaction
Next: 7/18/2022: Arch Systems venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary